Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Adcy6 | |
NM_007405 |
adenylate cyclase 6 (Adcy6), mRNA [NM_007405] |
KLA | 1.10 |
1.16 |
1.16 |
1.09 |
1.08 |
1.06 |
.99 |
| ATP | 1.05 |
.97 |
1.08 |
1.12 |
1.08 |
1.08 |
1.04 |
| KLA/ATP | 1.14 |
1.20 |
1.29 |
1.30 |
1.25 |
1.11 |
1.07 |
|
Adcy9 | |
NM_009624 |
adenylate cyclase 9 (Adcy9), mRNA [NM_009624] |
KLA | .18 |
.15 |
.13 |
.15 |
.17 |
.19 |
.33 |
| ATP | 1.33 |
1.16 |
.97 |
.98 |
.62 |
.56 |
.86 |
| KLA/ATP | .19 |
.16 |
.17 |
.18 |
.20 |
.25 |
.38 |
|
AK078587
| |
AK078587 |
11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] |
KLA | 1.37 |
1.28 |
1.13 |
1.06 |
1.15 |
1.31 |
1.22 |
| ATP | 1.04 |
1.08 |
1.21 |
1.22 |
1.27 |
1.12 |
1.14 |
| KLA/ATP | 1.48 |
1.66 |
1.97 |
1.26 |
1.17 |
1.03 |
1.28 |
|
Ap2a1 | |
NM_007458 |
adaptor protein complex AP-2, alpha 1 subunit (Ap2a1), transcript variant 1, mRNA [NM_007458] |
KLA | .92 |
1.14 |
1.16 |
.91 |
1.06 |
1.21 |
1.21 |
| ATP | 1.24 |
1.66 |
.77 |
1.57 |
1.08 |
.88 |
1.32 |
| KLA/ATP | 1.36 |
1.16 |
.56 |
1.31 |
.71 |
1.02 |
1.46 |
|
Ap2a2 | |
NM_007459 |
adaptor protein complex AP-2, alpha 2 subunit (Ap2a2), mRNA [NM_007459] |
KLA | .89 |
.90 |
.92 |
.77 |
.91 |
.83 |
.86 |
| ATP | 1.14 |
1.15 |
.86 |
1.08 |
.78 |
.53 |
1.29 |
| KLA/ATP | .94 |
.98 |
.67 |
.85 |
.54 |
.51 |
.99 |
|
Ap2b1 | |
AK030505 |
adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330422K01 product:adaptor-related protein complex 2, beta 1 subunit, full insert sequence. [AK030505] |
KLA | 1.84 |
1.44 |
1.49 |
1.36 |
1.58 |
1.21 |
1.05 |
| ATP | .78 |
.61 |
.53 |
.74 |
1.81 |
1.99 |
1.09 |
| KLA/ATP | 1.32 |
1.13 |
.92 |
1.01 |
2.31 |
1.59 |
1.18 |
|
Ap2b1 | |
NM_001035854 |
adaptor-related protein complex 2, beta 1 subunit (Ap2b1), transcript variant 1, mRNA [NM_001035854] |
KLA | 2.27 |
2.24 |
2.05 |
2.41 |
2.07 |
2.26 |
1.93 |
| ATP | .91 |
.89 |
1.02 |
1.00 |
.92 |
2.14 |
3.06 |
| KLA/ATP | 1.94 |
2.11 |
2.16 |
1.95 |
1.67 |
1.61 |
4.01 |
|
Ap2m1 | |
AK141862 |
12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130035H06 product:adaptor protein complex AP-2, mu1, full insert sequence [AK141862] |
KLA | .80 |
.69 |
.92 |
.86 |
.81 |
.97 |
.67 |
| ATP | 1.09 |
.73 |
.91 |
.85 |
2.29 |
1.04 |
.60 |
| KLA/ATP | .87 |
.60 |
.76 |
.96 |
2.66 |
.86 |
.59 |
|
Ap2m1 | |
NM_009679 |
adaptor protein complex AP-2, mu1 (Ap2m1), mRNA [NM_009679] |
KLA | .81 |
.86 |
.90 |
.77 |
.88 |
.92 |
1.12 |
| ATP | 1.06 |
1.28 |
.69 |
.98 |
.77 |
.64 |
1.24 |
| KLA/ATP | 1.00 |
1.03 |
.51 |
.87 |
.54 |
.67 |
1.01 |
|
Ap2s1 | |
NM_198613 |
adaptor-related protein complex 2, sigma 1 subunit (Ap2s1), mRNA [NM_198613] |
KLA | .91 |
.94 |
.95 |
.87 |
.96 |
.98 |
.82 |
| ATP | 1.01 |
1.09 |
.66 |
.94 |
.67 |
.64 |
1.39 |
| KLA/ATP | 1.05 |
1.02 |
.67 |
.97 |
.69 |
.82 |
1.19 |
|
Atp1a1 | |
NM_144900 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] |
KLA | .78 |
.94 |
.68 |
.81 |
.62 |
.55 |
.75 |
| ATP | 1.02 |
1.05 |
.86 |
.85 |
1.77 |
2.54 |
1.11 |
| KLA/ATP | .83 |
.99 |
.80 |
.75 |
.91 |
1.15 |
.68 |
|
Atp1a2 | |
NM_178405 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] |
KLA | 1.03 |
.98 |
1.03 |
1.05 |
1.03 |
.98 |
1.02 |
| ATP | 1.03 |
.98 |
1.06 |
1.05 |
1.05 |
.93 |
1.07 |
| KLA/ATP | 1.04 |
1.05 |
1.02 |
1.02 |
.98 |
.92 |
1.02 |
|
Atp1a3 | |
AK053751 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] |
KLA | .88 |
.87 |
.74 |
.80 |
.84 |
.88 |
.93 |
| ATP | .96 |
.83 |
.80 |
.88 |
.94 |
.89 |
1.15 |
| KLA/ATP | .89 |
.86 |
.79 |
.90 |
.93 |
.84 |
.92 |
|
Atp1a3 | |
NM_144921 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] |
KLA | .99 |
.87 |
.96 |
.86 |
.81 |
.61 |
.52 |
| ATP | 1.22 |
1.21 |
1.16 |
1.38 |
1.27 |
.92 |
1.30 |
| KLA/ATP | .96 |
1.10 |
1.17 |
1.42 |
1.11 |
.91 |
.93 |
|
Atp1b1 | |
NM_009721 |
ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] |
KLA | .97 |
1.02 |
1.08 |
.98 |
.95 |
1.01 |
1.09 |
| ATP | 1.07 |
1.05 |
1.09 |
1.09 |
1.02 |
1.17 |
1.11 |
| KLA/ATP | .99 |
.99 |
.93 |
1.02 |
1.00 |
1.07 |
1.04 |
|
Atp1b2 | |
NM_013415 |
ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] |
KLA | 1.18 |
1.09 |
1.11 |
1.12 |
1.16 |
1.12 |
1.15 |
| ATP | .95 |
.98 |
.99 |
1.26 |
1.06 |
1.10 |
1.07 |
| KLA/ATP | 1.15 |
1.16 |
1.09 |
1.19 |
1.27 |
1.13 |
1.02 |
|
Atp1b3 | |
NM_007502 |
ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] |
KLA | 1.86 |
2.10 |
2.25 |
2.21 |
2.68 |
3.26 |
3.45 |
| ATP | 1.08 |
1.09 |
.93 |
1.13 |
1.55 |
2.14 |
2.38 |
| KLA/ATP | 1.95 |
2.10 |
1.84 |
2.34 |
2.20 |
2.96 |
4.69 |
|
Atp1b4 | |
NM_133690 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] |
KLA | .99 |
1.02 |
1.03 |
1.01 |
.95 |
.90 |
1.00 |
| ATP | 1.00 |
1.05 |
1.04 |
.98 |
1.07 |
.98 |
.97 |
| KLA/ATP | 1.00 |
1.05 |
1.03 |
1.04 |
.96 |
.97 |
1.01 |
|
Atp2b1 | |
AK053569 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111D10 product:unclassifiable, full insert sequence. [AK053569] |
KLA | 1.18 |
1.02 |
.86 |
.87 |
.88 |
.99 |
.97 |
| ATP | 1.38 |
1.60 |
8.03 |
2.45 |
1.66 |
1.16 |
.94 |
| KLA/ATP | 1.32 |
1.41 |
6.67 |
1.98 |
1.15 |
1.08 |
.96 |
|
Atp2b1 | |
AK161995 |
12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720440F18 product:Plasma membrane calcium pump isoform 1b (Fragment) homolog [Canis familiaris], full insert sequence. [AK16199 |
KLA | 1.64 |
1.50 |
1.23 |
1.02 |
.71 |
.75 |
.92 |
| ATP | 1.04 |
1.12 |
1.69 |
1.64 |
1.34 |
1.03 |
.66 |
| KLA/ATP | 1.69 |
1.58 |
2.20 |
1.99 |
1.03 |
.67 |
.57 |
|
Atp2b1 | |
NM_026482 |
ATPase, Ca++ transporting, plasma membrane 1 (Atp2b1), mRNA [NM_026482] |
KLA | 1.91 |
1.76 |
1.64 |
1.21 |
.84 |
.79 |
1.07 |
| ATP | 1.00 |
1.01 |
1.43 |
2.32 |
2.28 |
1.71 |
1.06 |
| KLA/ATP | 1.86 |
1.85 |
2.23 |
2.48 |
1.71 |
1.05 |
1.04 |
|
Bdkrb2 | |
NM_009747 |
bradykinin receptor, beta 2 (Bdkrb2), mRNA [NM_009747] |
KLA | .97 |
.96 |
1.01 |
1.09 |
1.01 |
1.00 |
1.08 |
| ATP | 1.07 |
.98 |
1.04 |
1.01 |
1.05 |
1.00 |
1.08 |
| KLA/ATP | 1.02 |
1.05 |
1.04 |
1.01 |
1.03 |
1.04 |
.98 |
|
Calb1 | |
NM_009788 |
calbindin-28K (Calb1), mRNA [NM_009788] |
KLA | 1.01 |
.99 |
1.00 |
.99 |
1.00 |
1.02 |
.99 |
| ATP | .99 |
1.00 |
1.01 |
1.03 |
.99 |
1.01 |
1.03 |
| KLA/ATP | 1.01 |
1.00 |
1.04 |
1.00 |
1.00 |
1.00 |
1.02 |
|
Clta | |
AK035903 |
16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630016K07 product:unclassifiable, full insert sequence [AK035903] |
KLA | 1.01 |
1.00 |
.97 |
1.02 |
1.01 |
1.12 |
1.09 |
| ATP | 1.04 |
.98 |
.91 |
1.05 |
1.02 |
1.01 |
.95 |
| KLA/ATP | 1.00 |
.99 |
.93 |
1.07 |
1.09 |
.98 |
.99 |
|
Clta | |
NM_016760 |
clathrin, light polypeptide (Lca) (Clta), transcript variant 3, mRNA [NM_016760] |
KLA | .68 |
.70 |
.75 |
.68 |
.70 |
.77 |
.55 |
| ATP | 1.06 |
1.05 |
.93 |
.97 |
.81 |
.60 |
.75 |
| KLA/ATP | .75 |
.76 |
.68 |
.71 |
.69 |
.64 |
.42 |
|
Cltb | |
NM_028870 |
clathrin, light polypeptide (Lcb) (Cltb), mRNA [NM_028870] |
KLA | .91 |
1.01 |
.97 |
.78 |
.71 |
.52 |
.73 |
| ATP | 1.15 |
1.32 |
1.07 |
1.72 |
1.96 |
1.94 |
1.31 |
| KLA/ATP | 1.07 |
1.17 |
.76 |
1.17 |
1.18 |
2.12 |
1.06 |
|
Cltc | |
AK039453 |
adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330045B10 product:CLATHRIN HEAVY CHAIN 1 (CLH-17) homolog [Homo sapiens], full insert sequence. [AK039453] |
KLA | 1.07 |
1.00 |
1.01 |
1.00 |
1.03 |
1.06 |
1.02 |
| ATP | 1.00 |
.99 |
1.02 |
.97 |
1.00 |
1.02 |
1.00 |
| KLA/ATP | 1.01 |
1.01 |
1.02 |
.98 |
1.04 |
.98 |
.99 |
|
Cltc | |
NM_001003908 |
clathrin, heavy polypeptide (Hc) (Cltc), mRNA [NM_001003908] |
KLA | .94 |
1.00 |
.98 |
.89 |
1.18 |
1.02 |
.93 |
| ATP | 1.21 |
1.42 |
.72 |
.89 |
.93 |
.96 |
.75 |
| KLA/ATP | 1.12 |
1.21 |
.48 |
.72 |
.57 |
.87 |
.81 |
|
Dnm1 | |
NM_010065 |
dynamin 1 (Dnm1), mRNA [NM_010065] |
KLA | .96 |
.92 |
.87 |
.88 |
.85 |
.79 |
1.16 |
| ATP | 1.05 |
1.08 |
.96 |
1.04 |
.93 |
.80 |
1.59 |
| KLA/ATP | .99 |
1.00 |
.82 |
.93 |
.79 |
.79 |
1.24 |
|
Dnm2 | |
NM_001039520 |
dynamin 2 (Dnm2), mRNA [NM_001039520] |
KLA | 1.00 |
1.03 |
1.14 |
1.01 |
1.29 |
1.47 |
1.30 |
| ATP | 1.11 |
1.31 |
.93 |
1.41 |
1.04 |
.90 |
1.53 |
| KLA/ATP | 1.26 |
1.23 |
.87 |
1.41 |
.86 |
.98 |
1.86 |
|
Dnm3 | |
NM_001038619 |
dynamin 3 (Dnm3), mRNA [NM_001038619] |
KLA | 1.00 |
1.01 |
1.02 |
1.02 |
1.03 |
.96 |
1.04 |
| ATP | 1.05 |
1.01 |
.99 |
.96 |
1.03 |
.97 |
.88 |
| KLA/ATP | 1.03 |
1.05 |
1.03 |
.99 |
.98 |
1.02 |
1.03 |
|
Esr1 | |
NM_007956 |
estrogen receptor 1 (alpha) (Esr1), mRNA [NM_007956] |
KLA | 1.06 |
1.05 |
1.11 |
1.36 |
1.33 |
1.02 |
.90 |
| ATP | 1.05 |
.92 |
1.02 |
.94 |
1.02 |
.83 |
.67 |
| KLA/ATP | 1.02 |
.98 |
1.09 |
1.08 |
1.32 |
1.07 |
.71 |
|
Fxyd2 | |
NM_052823 |
FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] |
KLA | 1.07 |
.97 |
1.09 |
.98 |
1.02 |
.96 |
.83 |
| ATP | 1.07 |
1.22 |
1.00 |
1.14 |
1.00 |
1.22 |
4.11 |
| KLA/ATP | 1.06 |
1.11 |
.96 |
1.13 |
.98 |
1.01 |
1.02 |
|
Gnaq | |
NM_008139 |
guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] |
KLA | .82 |
.82 |
.69 |
.64 |
.60 |
.55 |
.55 |
| ATP | 1.06 |
1.02 |
.87 |
.67 |
.50 |
.66 |
.57 |
| KLA/ATP | .82 |
.79 |
.66 |
.55 |
.41 |
.33 |
.48 |
|
Gnas | |
AF107847 |
neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] |
KLA | 1.04 |
.94 |
1.00 |
1.05 |
1.04 |
.98 |
1.00 |
| ATP | .98 |
.97 |
.96 |
1.00 |
.99 |
.98 |
1.02 |
| KLA/ATP | 1.04 |
1.02 |
.96 |
.95 |
1.01 |
.96 |
1.01 |
|
Gnas | |
AK017423 |
10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] |
KLA | .85 |
1.08 |
.97 |
.92 |
1.05 |
1.03 |
1.08 |
| ATP | .99 |
1.30 |
2.11 |
1.73 |
1.23 |
1.01 |
1.02 |
| KLA/ATP | .96 |
1.06 |
1.58 |
1.34 |
1.29 |
1.05 |
.91 |
|
Gnas | |
NM_001077510 |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] |
KLA | .99 |
1.03 |
.97 |
.91 |
1.03 |
.95 |
.97 |
| ATP | 1.04 |
1.19 |
1.15 |
1.61 |
1.24 |
.91 |
1.00 |
| KLA/ATP | 1.06 |
.97 |
1.01 |
1.46 |
1.04 |
.85 |
1.01 |
|
Gnas | |
S49980 |
gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] |
KLA | .91 |
.88 |
1.03 |
.87 |
.90 |
.84 |
1.01 |
| ATP | 1.16 |
1.22 |
1.02 |
1.55 |
1.16 |
.80 |
.99 |
| KLA/ATP | 1.01 |
1.13 |
.86 |
1.12 |
.97 |
.85 |
1.08 |
|
Kl | |
AB010088 |
mRNA for secreted isoform of Klotho protein, complete cds [AB010088] |
KLA | 1.02 |
1.00 |
1.01 |
.97 |
1.02 |
1.04 |
1.01 |
| ATP | 1.03 |
1.03 |
.99 |
1.00 |
.99 |
.97 |
1.01 |
| KLA/ATP | 1.03 |
.93 |
.98 |
.87 |
.96 |
.92 |
.93 |
|
Kl | |
NM_013823 |
klotho (Kl), mRNA [NM_013823] |
KLA | .97 |
.96 |
1.08 |
.95 |
1.01 |
.95 |
1.05 |
| ATP | .96 |
1.07 |
1.02 |
1.06 |
1.05 |
1.00 |
1.02 |
| KLA/ATP | .95 |
1.02 |
1.04 |
1.04 |
1.11 |
1.01 |
.96 |
|
Klk1 | |
NM_010639 |
kallikrein 1 (Klk1), mRNA [NM_010639] |
KLA | 1.01 |
.98 |
1.26 |
1.09 |
1.09 |
.97 |
1.06 |
| ATP | 1.08 |
1.03 |
1.10 |
1.00 |
1.01 |
.90 |
1.05 |
| KLA/ATP | .99 |
1.04 |
1.08 |
1.06 |
1.02 |
1.05 |
1.04 |
|
Klk1b1 | |
NM_010645 |
kallikrein 1-related peptidase b1 (Klk1b1), mRNA [NM_010645] |
KLA | .89 |
1.02 |
.98 |
1.03 |
1.03 |
.95 |
1.11 |
| ATP | 1.05 |
1.03 |
1.02 |
1.01 |
1.04 |
.98 |
1.01 |
| KLA/ATP | .99 |
1.00 |
.99 |
.98 |
.97 |
1.06 |
.99 |
|
Klk1b11 | |
NM_010640 |
kallikrein 1-related peptidase b11 (Klk1b11), mRNA [NM_010640] |
KLA | .99 |
.96 |
1.00 |
.99 |
1.00 |
1.00 |
.76 |
| ATP | 1.04 |
1.05 |
1.07 |
1.06 |
1.02 |
1.17 |
1.50 |
| KLA/ATP | .93 |
.94 |
.98 |
.97 |
.97 |
1.07 |
1.20 |
|
Klk1b21 | |
NM_010642 |
kallikrein 1-related peptidase b21 (Klk1b21), mRNA [NM_010642] |
KLA | 1.01 |
.99 |
.98 |
.94 |
.96 |
.96 |
1.01 |
| ATP | 1.02 |
.97 |
.98 |
1.00 |
1.03 |
1.02 |
1.04 |
| KLA/ATP | .92 |
.98 |
1.06 |
1.07 |
.93 |
1.02 |
1.04 |
|
Klk1b24 | |
NM_010643 |
kallikrein 1-related peptidase b24 (Klk1b24), mRNA [NM_010643] |
KLA | .99 |
.99 |
1.00 |
.97 |
.92 |
.95 |
.97 |
| ATP | .94 |
.98 |
1.03 |
1.00 |
.96 |
1.00 |
.98 |
| KLA/ATP | 1.02 |
1.03 |
1.09 |
1.00 |
1.00 |
1.01 |
.92 |
|
Klk1b26 | |
NM_010644 |
kallikrein 1-related petidase b26 (Klk1b26), mRNA [NM_010644] |
KLA | 1.01 |
.98 |
.99 |
.96 |
.96 |
1.01 |
.95 |
| ATP | .93 |
1.07 |
.99 |
.94 |
.92 |
1.00 |
1.05 |
| KLA/ATP | .93 |
.97 |
.99 |
.94 |
.99 |
.94 |
1.03 |
|
Klk1b3 | |
NM_008693 |
kallikrein 1-related peptidase b3 (Klk1b3), mRNA [NM_008693] |
KLA | 1.13 |
1.16 |
1.13 |
1.19 |
1.20 |
1.24 |
1.24 |
| ATP | .99 |
1.04 |
1.10 |
1.08 |
1.03 |
1.05 |
1.04 |
| KLA/ATP | 1.15 |
1.18 |
1.08 |
1.16 |
1.08 |
1.12 |
1.25 |
|
Klk1b8 | |
NM_008457 |
kallikrein 1-related peptidase b8 (Klk1b8), mRNA [NM_008457] |
KLA | 1.01 |
.97 |
1.01 |
1.06 |
1.02 |
1.08 |
1.07 |
| ATP | 1.01 |
1.02 |
1.00 |
.98 |
1.04 |
1.10 |
1.00 |
| KLA/ATP | 1.08 |
1.12 |
1.07 |
1.07 |
1.04 |
1.08 |
1.03 |
|
Klk1b9 | |
NM_010116 |
kallikrein 1-related peptidase b9 (Klk1b9), mRNA [NM_010116] |
KLA | .98 |
1.06 |
1.08 |
.97 |
1.09 |
1.16 |
1.02 |
| ATP | 1.00 |
.99 |
.92 |
1.01 |
.98 |
.94 |
.93 |
| KLA/ATP | 1.10 |
1.12 |
1.02 |
1.04 |
.96 |
1.01 |
1.00 |
|
Mm.13573 4 | |
111186473 |
Unknown |
KLA | .94 |
1.00 |
.98 |
.96 |
.99 |
1.02 |
.97 |
| ATP | 1.02 |
1.06 |
.96 |
.95 |
.99 |
.99 |
.99 |
| KLA/ATP | .99 |
1.03 |
.99 |
.97 |
.96 |
1.06 |
1.01 |
|
Mm.24508 4 | |
144227202 |
Unknown |
KLA | 1.06 |
1.07 |
1.19 |
1.42 |
1.09 |
.83 |
.67 |
| ATP | .99 |
1.02 |
1.16 |
1.40 |
1.51 |
1.67 |
1.61 |
| KLA/ATP | 1.04 |
1.06 |
1.35 |
1.56 |
1.65 |
1.92 |
2.49 |
|
Mm.29002 6 | |
146141141 |
Unknown |
KLA | .86 |
.76 |
.74 |
.94 |
.70 |
.57 |
.57 |
| ATP | 1.05 |
.94 |
1.16 |
1.33 |
2.13 |
2.57 |
1.15 |
| KLA/ATP | .74 |
.84 |
1.09 |
1.07 |
1.49 |
2.42 |
1.05 |
|
Mm.44160 1 | |
145966786 |
Unknown |
KLA | 1.08 |
.94 |
1.01 |
.97 |
.79 |
.78 |
.71 |
| ATP | 1.09 |
.92 |
1.10 |
.75 |
.65 |
.92 |
.69 |
| KLA/ATP | 1.01 |
.92 |
1.16 |
.81 |
.69 |
.56 |
.63 |
|
Mm.44329 2 | |
195546951 |
Unknown |
KLA | 1.01 |
1.02 |
1.09 |
1.04 |
1.00 |
1.00 |
.81 |
| ATP | .98 |
1.01 |
1.14 |
1.05 |
1.02 |
1.22 |
1.31 |
| KLA/ATP | 1.01 |
1.01 |
.98 |
1.10 |
1.07 |
1.10 |
1.08 |
|
Plcb1 | |
AK129166 |
mRNA for mKIAA0581 protein [AK129166] |
KLA | 1.02 |
.98 |
.91 |
.91 |
.92 |
.95 |
.89 |
| ATP | 1.03 |
1.02 |
1.02 |
1.01 |
.90 |
1.02 |
1.04 |
| KLA/ATP | .98 |
.97 |
.91 |
.93 |
.92 |
1.01 |
1.16 |
|
Plcb1 | |
NM_019677 |
phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] |
KLA | .99 |
.94 |
.95 |
.97 |
.93 |
.92 |
.91 |
| ATP | 1.00 |
.96 |
.99 |
.95 |
.99 |
1.03 |
.98 |
| KLA/ATP | .93 |
.96 |
.94 |
.93 |
.87 |
1.00 |
1.06 |
|
Plcb2 | |
NM_177568 |
phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] |
KLA | .70 |
.68 |
.64 |
.67 |
.65 |
.76 |
.88 |
| ATP | .95 |
.94 |
1.04 |
.94 |
.72 |
.57 |
1.19 |
| KLA/ATP | .69 |
.68 |
.72 |
.63 |
.65 |
.55 |
.70 |
|
Plcb3 | |
NM_008874 |
phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] |
KLA | 1.72 |
1.78 |
1.82 |
1.65 |
1.67 |
1.44 |
1.21 |
| ATP | .97 |
1.04 |
.81 |
.87 |
.78 |
.88 |
.94 |
| KLA/ATP | 1.69 |
1.89 |
1.44 |
1.66 |
1.12 |
.73 |
.93 |
|
Plcb4 | |
AK082509 |
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] |
KLA | 1.06 |
1.03 |
.97 |
.98 |
1.02 |
1.01 |
.99 |
| ATP | .99 |
1.07 |
1.09 |
.95 |
.97 |
.97 |
1.02 |
| KLA/ATP | .98 |
1.00 |
1.03 |
.96 |
1.02 |
.91 |
.98 |
|
Plcb4 | |
NM_013829 |
phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] |
KLA | .88 |
.94 |
.81 |
.82 |
.81 |
.86 |
1.01 |
| ATP | 1.00 |
1.01 |
.92 |
.93 |
.88 |
.85 |
.89 |
| KLA/ATP | .97 |
.94 |
.78 |
.80 |
.78 |
.86 |
.97 |
|
Prkaca | |
NM_008854 |
protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] |
KLA | .71 |
.74 |
.72 |
.70 |
.72 |
.84 |
.85 |
| ATP | 1.05 |
.98 |
.89 |
.92 |
.76 |
.60 |
1.02 |
| KLA/ATP | .79 |
.74 |
.55 |
.65 |
.60 |
.65 |
.93 |
|
Prkacb | |
NM_011100 |
protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] |
KLA | .69 |
.70 |
.66 |
.58 |
.51 |
.55 |
.59 |
| ATP | 1.02 |
1.19 |
.97 |
1.01 |
.69 |
.38 |
.56 |
| KLA/ATP | .72 |
.73 |
.57 |
.62 |
.47 |
.41 |
.45 |
|
Prkca | |
NM_011101 |
protein kinase C, alpha (Prkca), mRNA [NM_011101] |
KLA | 1.00 |
.96 |
.94 |
.95 |
.95 |
.89 |
.96 |
| ATP | 1.00 |
1.03 |
.91 |
.94 |
.82 |
.87 |
1.13 |
| KLA/ATP | 1.02 |
.95 |
.91 |
.86 |
.78 |
.84 |
.94 |
|
Prkcb1 | |
NM_008855 |
protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] |
KLA | .92 |
.95 |
.93 |
.78 |
.77 |
1.08 |
1.83 |
| ATP | 1.03 |
1.12 |
1.09 |
1.23 |
.90 |
2.08 |
.96 |
| KLA/ATP | .98 |
.99 |
.82 |
.89 |
.62 |
1.01 |
1.08 |
|
Prkcc | |
NM_011102 |
protein kinase C, gamma (Prkcc), mRNA [NM_011102] |
KLA | 1.02 |
1.04 |
1.11 |
1.04 |
.96 |
1.02 |
1.05 |
| ATP | .98 |
.98 |
1.05 |
1.03 |
1.08 |
.96 |
.95 |
| KLA/ATP | 1.21 |
1.16 |
1.09 |
1.07 |
1.04 |
.98 |
.93 |
|
Prkx | |
NM_016979 |
protein kinase, X-linked (Prkx), mRNA [NM_016979] |
KLA | 3.61 |
3.79 |
4.67 |
4.66 |
4.85 |
4.19 |
1.43 |
| ATP | .98 |
.90 |
.63 |
.61 |
1.12 |
1.90 |
1.29 |
| KLA/ATP | 3.56 |
3.36 |
2.62 |
2.06 |
2.26 |
2.87 |
2.31 |
|
Pthr1 | |
NM_011199 |
parathyroid hormone receptor 1 (Pthr1), transcript variant 1, mRNA [NM_011199] |
KLA | .82 |
.90 |
.89 |
.94 |
.88 |
.86 |
.93 |
| ATP | 1.08 |
.95 |
.93 |
.89 |
.83 |
.86 |
.85 |
| KLA/ATP | .95 |
.87 |
.81 |
.86 |
.91 |
.93 |
.87 |
|
Rab11a | |
NM_017382 |
RAB11a, member RAS oncogene family (Rab11a), mRNA [NM_017382] |
KLA | .96 |
.92 |
.94 |
.94 |
1.01 |
1.05 |
1.00 |
| ATP | 1.04 |
1.08 |
1.09 |
1.15 |
.88 |
.73 |
.87 |
| KLA/ATP | .99 |
.98 |
.96 |
1.03 |
.84 |
.74 |
.97 |
|
Slc8a1 | |
AF004666 |
sodium-calcium exchanger (NCX1) mRNA, complete cds. [AF004666] |
KLA | 1.13 |
1.10 |
1.22 |
1.44 |
1.52 |
1.55 |
1.10 |
| ATP | 1.03 |
1.05 |
1.22 |
1.12 |
.65 |
.49 |
.67 |
| KLA/ATP | 1.04 |
1.21 |
1.30 |
1.44 |
.81 |
.63 |
1.01 |
|
Slc8a1 | |
AF108396 |
sodium/calcium exchanger isoform NaCa3 (Ncx1) mRNA, partial cds. [AF108396] |
KLA | 1.07 |
1.18 |
1.30 |
1.22 |
1.31 |
1.39 |
1.21 |
| ATP | 1.03 |
1.02 |
1.10 |
1.07 |
.88 |
.91 |
1.23 |
| KLA/ATP | 1.15 |
1.17 |
1.14 |
1.22 |
.96 |
1.01 |
1.77 |
|
Slc8a1 | |
NM_011406 |
solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), transcript variant A, mRNA [NM_011406] |
KLA | 1.12 |
1.16 |
1.22 |
1.25 |
1.35 |
1.33 |
1.11 |
| ATP | 1.03 |
1.04 |
1.07 |
1.10 |
.93 |
.90 |
1.19 |
| KLA/ATP | 1.13 |
1.24 |
1.19 |
1.16 |
.93 |
1.06 |
1.62 |
|
Trpv5 | |
NM_001007572 |
transient receptor potential cation channel, subfamily V, member 5 (Trpv5), mRNA [NM_001007572] |
KLA | 1.00 |
.96 |
1.03 |
.99 |
.98 |
.95 |
.87 |
| ATP | .98 |
1.01 |
.96 |
1.01 |
1.00 |
1.05 |
1.01 |
| KLA/ATP | .99 |
1.08 |
1.08 |
.98 |
.92 |
.95 |
.95 |
|
Vdr | |
NM_009504 |
vitamin D receptor (Vdr), mRNA [NM_009504] |
KLA | 1.01 |
1.01 |
1.12 |
1.12 |
1.09 |
.96 |
.94 |
| ATP | .99 |
1.03 |
1.09 |
1.19 |
1.25 |
1.24 |
1.36 |
| KLA/ATP | .99 |
1.03 |
1.03 |
1.28 |
1.21 |
1.42 |
1.76 |
|